Bank of New York Mellon’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-13,475
| Closed | -$143K | – | 4318 |
|
2018
Q1 | $143K | Sell |
13,475
-843
| -6% | -$8.95K | ﹤0.01% | 3985 |
|
2017
Q4 | $604K | Buy |
14,318
+714
| +5% | +$30.1K | ﹤0.01% | 3515 |
|
2017
Q3 | $748K | Buy |
13,604
+771
| +6% | +$42.4K | ﹤0.01% | 3382 |
|
2017
Q2 | $2.38M | Buy |
12,833
+2,725
| +27% | +$505K | ﹤0.01% | 2751 |
|
2017
Q1 | $1.21M | Buy |
10,108
+15
| +0.1% | +$1.79K | ﹤0.01% | 3138 |
|
2016
Q4 | $1M | Buy |
10,093
+354
| +4% | +$35.1K | ﹤0.01% | 3262 |
|
2016
Q3 | $1.09M | Buy |
9,739
+714
| +8% | +$80K | ﹤0.01% | 3121 |
|
2016
Q2 | $928K | Buy |
9,025
+2,546
| +39% | +$262K | ﹤0.01% | 3187 |
|
2016
Q1 | $596K | Buy |
6,479
+135
| +2% | +$12.4K | ﹤0.01% | 3354 |
|
2015
Q4 | $915K | Buy |
6,344
+4,009
| +172% | +$578K | ﹤0.01% | 3219 |
|
2015
Q3 | $242K | Buy |
+2,335
| New | +$242K | ﹤0.01% | 3800 |
|